Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence
Por:
Egea, OI, Spitaleri, G, Domingo, M, Revuelta-Lopez E, Codina, P, Cediel, G, Vacas, ES, Cserkoova, A, Figal, DP, Nunez, J, Lupon, J and Genis, AB
Publicada:
1 oct 2021
Resumen:
Filiaciones:
:
Hlth Sci Res Inst Germans Trias & Pujol IGTP, Badalona, Spain
Spitaleri, G:
Germans Trias & Pujol Hosp, Cardiol, Badalona, Spain
:
Germans Trias & Pujol Hosp, Cardiol, Badalona, Spain
:
Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Heart Failure & Cardiac Regenerat Res Progr, Badalona, Spain
:
Germans Trias & Pujol Hosp, Cardiol, Badalona, Spain
:
Germans Trias & Pujol Hosp, Cardiol, Badalona, Spain
:
Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Heart Failure & Cardiac Regenerat Res Progr, Badalona, Spain
Figal, DP:
Hosp Univ Virgen Arrixaca, Cardiol, Murcia, Spain
Nunez, J:
Univ Valencia, Cardiol, Valencia, Spain
:
Univ Valencia, Cardiol, Valencia, Spain
:
Germans Trias & Pujol Hosp, Cardiol, Badalona, Spain
|